Physician profile
Christopher Reiff
NPI 1871911768
$3,312.20
in general payments reported to CMS, 2019-2025
4 companies · $2,231 in 2025
The $2,231 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.97 · 2021: $657 · 2023: $167 · 2024: $206 · 2025: $2,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,231 · Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,231.25 |
| Food and Beverage | $373.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,078.20 | 2021-2025 | Ensite |
| Heartflow, INC. | $167.16 | 2023 | Ffrct |
| Getinge USA Sales, LLC | $50.97 | 2020 | |
| Edwards Lifesciences Corporation | $15.87 | 2024 | Pascal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Reiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.